News

Centre for Genomic Regulation teams up with Almirall to develop new preclinical models for...

Global biopharmaceutical company Almirall has entered into a research collaboration with the Centre for Genomic Regulation (CRG), an international biomedical research institute of excellence....

Y-mAbs’ DANYELZA approved in Brazil for the treatment of high-risk neuroblastoma

The Brazilian Health Regulatory Agency, Agência Nacional de Vigilância Sanitária (Anvisa) has granted marketing authorization for Y-mAbs Therapeutics' DANYELZA (naxitamab-gqgk) 40mg/10mL injection. DANYELZA will...

Innoviva Specialty Therapeutics receives FDA approval for pneumonia treatment XACDURO

The U.S. Food and Drug Administration (FDA) has approved Innoviva Specialty Therapeutics' XACDURO (sulbactam for injection; durlobactam for injection), co-packaged for intravenous use in...